The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Between 2026 And 2030?
The market size for messenger ribonucleic acid (mRNA) manufacturing services has experienced rapid growth in recent years. It is anticipated to increase from $6.14 billion in 2025 to $7.12 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.9%. The historical expansion of this market can be attributed to factors such as the rise in mRNA therapeutics research, demand for emergency vaccine manufacturing, limited in-house mRNA capacity, an increase in CDMO partnerships, and the expansion of biotechnology pipelines.
The messenger ribonucleic acid (mRNA) manufacturing service market is poised for significant growth in the coming years. This market is forecast to reach a value of $12.97 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 16.2%. This expansion during the forecast timeframe is primarily driven by factors such as an uptick in mRNA therapy trials, increasing demand for contract manufacturing, advancements in personalized medicine, higher outsourcing by biotechnology companies, and the scaling up of commercial mRNA products. Key trends anticipated within this period encompass integrated mRNA process development services, large scale in vitro transcription production, end to end LNP encapsulation services, rapid technology transfer programs, and GMP-grade mRNA batch manufacturing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33216&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?
Increased clinical trial engagement is projected to boost the expansion of the messenger ribonucleic acid (mRNA) manufacturing service market moving ahead. Clinical trial activity encompasses all stages involved in executing and overseeing clinical investigations aimed at assessing medical treatments in human subjects. This activity is on the rise, driven by the growing embrace of digital and decentralized trial methodologies that facilitate quicker patient enrollment, distant oversight, and more streamlined data gathering across wider demographics. Messenger ribonucleic acid (mRNA) manufacturing services support clinical trial efforts by providing swift and adaptable production of mRNA-based treatments, ensuring prompt delivery for various trial phases and speeding up drug development. For example, in December 2024, data from the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade body, indicated that industry-sponsored clinical trials started in the UK rose to 426 in 2023, up from 411 in 2022. Consequently, the heightened clinical trial activity is fueling the expansion of the messenger ribonucleic acid (mRNA) manufacturing service market.
Which Market Segments Are Examined In The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Study?
The messenger ribonucleic acid (mrna) manufacturing service market covered in this report is segmented –
1) By Service Type: Process Development; Analytical Testing; Manufacturing; Fill-Finish; Other Service Types
2) By Scale of Operation: Research And Preclinical Scale; Clinical Scale; Commercial Scale
3) By Application: Vaccines; Therapeutics; Research; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Process Development: Template Design And Optimization; In Vitro Transcription Process Design; Formulation Development; Process Scale-Up And Technology Transfer; Process Validation Support
2) By Analytical Testing: Identity And Purity Testing; Potency And Functional Assays; Impurity And Contaminant Analysis; Stability And Shelf Life Studies; Quality Control Release Testing
3) By Manufacturing: Plasmid Deoxyribonucleic Acid Production; In Vitro Transcription Manufacturing; Enzymatic Capping And Tailoring; Purification And Concentration; Large-Scale Batch Production
4) By Fill-Finish: Aseptic Filling Services; Vial And Syringe Filling; Lyophilization Services; Labeling And Packaging; Cold Chain Handling And Storage
5) By Other Service Types: Regulatory Support Services; Quality Assurance And Documentation; Supply Chain And Logistics Support; Technology Consulting Services; Custom Manufacturing Solutions
Which Trends Are Influencing The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?
Leading companies within the messenger ribonucleic acid (mRNA) manufacturing service market are concentrating on developing advanced solutions, such as in vitro transcription (IVT), aimed at accelerating the production of premium, clinical-grade mRNA essential for vaccines and individualized treatments. In vitro transcription (IVT) is a lab procedure where messenger RNA (mRNA) is synthesized from a DNA template using RNA polymerase enzymes, allowing mRNA production externally from living cells for various applications including research, therapeutics, or vaccines. As an illustration, in May 2025, GenScript Biotech Corporation, a Chinese biotechnology firm, introduced a GMP-like mRNA manufacturing service designed to facilitate preclinical investigations and research enabling Investigational New Drug (IND) applications. This service delivers high-purity, scalable in vitro transcription (IVT) processes, maintaining strict oversight of crucial quality parameters like capping efficiency, poly(A) tail length, and impurity profiles. It further aids swift progression from preclinical to clinical phases by ensuring consistent batch production, offering adaptable customization for diverse mRNA constructs, and shortening overall development timelines. Moreover, the GMP-like framework guarantees readiness for regulatory submissions through improved traceability, standardized operational procedures, and thorough quality documentation, thereby assisting developers in mitigating risks associated with later-stage manufacturing and expediting clinical advancement.
Which Companies Hold Significant Positions In The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?
Major companies operating in the messenger ribonucleic acid (mrna) manufacturing service market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Biotechnologies, Evonik Industries AG, Lonza Group AG, Charles River Laboratories International Inc., Samsung Biologics Co. Ltd., WuXi Biologics Inc., Recipharm AB, Curia Global Inc., Emergent BioSolutions Inc., AGC Biologics Inc., Corden Pharma International GmbH, Rentschler Biopharma SE, GenScript ProBio, ST Pharm Co. Ltd., etherna Immunotherapies NV, BIOMAY AG., Porton Advanced Solutions Ltd., Wacker Biotech GmbH.
Read the full messenger ribonucleic acid (mrna) manufacturing service market report here:
How Does The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Perform Across Major Global Regions?
North America was the largest region in the mRNA manufacturing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) manufacturing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33216&type=smp
Browse Through More Reports Similar to the Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Ribonucleic Acid Rna Sequencing Market Report 2026
Nucleic Acid Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/nucleic-acid-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model